Previous 10 | Next 10 |
Align Technology press release (NASDAQ:ALGN): Q1 Non-GAAP EPS of $2.13 misses by $0.10. Revenue of $973.22M (+8.8% Y/Y) misses by $26.18M. As of March 31, 2022, we had $1.1 billion in cash, cash equivalents and short-term and long-term marketable securities, compared to $1.3 billion as of Dec...
Q1'22 total revenues of $973.2 million, compared to $894.8 million in Q1'21 Q1'22 Invisalign volume of 598.8 thousand cases, compared to 595.8 thousand cases in Q1'21 Q1'22 Invisalign cases for teenage patients of 175.2 thousand cases, 29.3% of total volumes, compared to 165.3 t...
As Danaher (DHR) is set to kick off the earnings season of the makers of Life Sciences & Diagnostic Tools on Thursday, Bank of America analysts led by Derik de Bruin issued cautious views on the subsector, citing macro and geopolitical headwinds. The earnings season for the group com...
After a couple of very unusual years in the stock market, it feels as if things are starting to get back to normal. And market volatility is bringing less speculative companies back into vogue. It's why I think investors wanting to put a little money to work should take a closer look at...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. After the Q4-2021 13F filings the consensus holdings were updated, 7 stocks were removed and 7 added from the unive...
Quidel recorded its best-ever revenue performance in 2021 at $1.699 billion despite its gross profit falling to $1.271 billion YOY. The fairly priced QuickVue At-Home OTC gave Quidel the impetus to enter retail and the home Covid-19 testing market. Reimbursement policies by third-...
Goldman Sachs equity strategists stressed the importance of pricing power for companies given a four-decade high in inflation and rising commodities prices. "Pricing power will become increasingly important in the face of continued inflation and cost pressures," David Kostin, chief U.S. equit...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion in Assets Under Management. After the Q4-2021 13F filings the consensus holdings were updated, 7 stocks were removed and 7 added from the un...
Who wants to be a millionaire? With the possible exception of billionaires, just about everyone does. The idea spawned a British (and then an American) quiz show. On television, it can happen overnight. In investing, becoming a millionaire takes time. Buying shares of high-performing co...
TEMPE, Ariz., April 05, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and re...
News, Short Squeeze, Breakout and More Instantly...
Align Technology Inc. Company Name:
ALGN Stock Symbol:
NASDAQ Market:
Align Technology Inc. Website:
2024-07-25 00:30:16 ET Image source: The Motley Fool. Align Technology (NASDAQ: ALGN) Q2 2024 Earnings Call Jul 24, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Align Technology (ALGN) Q2 2024 Earnings Call Transcript
Total Invisalign® patients surpasses 18 million globally, including over 5 million teens and kids Q2'24 total revenues of $1,028.5 million, increased 3.1% sequentially, and increased 2.6% year-over-year, and Q2'24 diluted net income per share was $1.28, or $2.41 on a non-GAAP diluted...
Offers doctors an intuitive way to design for in-practice 3D printing of models, bite splints, and restorations, leveraging the power of exocad CAD/CAM software with simplified doctor and staff-friendly design applications. Seamlessly integrated with leading 3D printers. Registration for ...